Provided by Tiger Fintech (Singapore) Pte. Ltd.

Oppenheimer

56.90
+1.071.92%
Post-market: 56.900.00000.00%19:32 EDT
Volume:70.72K
Turnover:4.01M
Market Cap:598.99M
PE:8.93
High:57.87
Open:56.03
Low:55.64
Close:55.83
Loading ...

Oppenheimer doesn’t see threat to Gilead estimates after HHS plans for HIV cuts

TIPRANKS
·
19 Mar

Goldman Sachs, Carlyle, Jefferies Downgraded by Oppenheimer Amid 'Likely' Delayed or Cancelled M&A Rebound

MT Newswires Live
·
19 Mar

Oppenheimer downgrades bank stocks

Investing.com
·
19 Mar

Carlyle downgraded to Perform at Oppenheimer on delayed M&A rebound

TIPRANKS
·
19 Mar

Oppenheimer downgrades Goldman Sachs to Perform on delayed M&A rebound

TIPRANKS
·
19 Mar

Cadence Design price target lowered to $200 from $225 at Oppenheimer

TIPRANKS
·
19 Mar

Oppenheimer downgrades Jefferies Financial as M&A rebound likely delayed

TIPRANKS
·
19 Mar

Oppenheimer Downgrades Jefferies Financial Group to Perform From Outperform

MT Newswires Live
·
19 Mar

Jefferies Financial downgraded to Perform from Outperform at Oppenheimer

TIPRANKS
·
19 Mar

Carlyle downgraded to Perform from Outperform at Oppenheimer

TIPRANKS
·
19 Mar

Goldman Sachs downgraded to Perform from Outperform at Oppenheimer

TIPRANKS
·
19 Mar

Oppenheimer Remains a Buy on Olema Pharmaceuticals (OLMA)

TIPRANKS
·
19 Mar

Olema Oncology price target lowered to $25 from $30 at Oppenheimer

TIPRANKS
·
19 Mar

Chewy Likely to Report Another 'Strong' Quarter, Oppenheimer Says

MT Newswires Live
·
19 Mar

Tesla's Declining Favorability Will Likely Dent Deliveries, Revenue in 2025, Oppenheimer Says

MT Newswires
·
19 Mar

Twilio's AI, Cross-Selling Strategy Could Drive Growth Above Targets, Oppenheimer Says

MT Newswires
·
18 Mar

Tesla Share Performance to Depend on Ability to Replace Portion of Consumer Base, Oppenheimer Says

MT Newswires
·
18 Mar

Oppenheimer Reaffirms Their Hold Rating on Cartesian Therapeutics (RNAC)

TIPRANKS
·
18 Mar

Oppenheimer Downgrades Sutro Biopharma to Market Perform From Outperform

MT Newswires Live
·
17 Mar

Oppenheimer Adjusts Price Target on Expedia Group to $230 From $235, Keeps Outperform Rating

MT Newswires Live
·
17 Mar